Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is more effective than finasteride for hair regrowth in male and female pattern hair loss, with similar side effects.

The 1565 nm non-ablative fractional laser is more effective and satisfying than 5% minoxidil for treating hair loss.

Using minoxidil with microneedling increases hair count for hair loss without serious side effects.

The document is about planning a review to assess if PRP alone is effective for treating hair loss in men and women.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Betamethasone is more effective long-term for alopecia areata than hydroxychloroquine.

The two lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.

Minoxidil is a popular hair growth treatment, but how it works isn't fully understood.

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.

Finasteride safety data in trials may be underreported or misrepresented.

Dutasteride is highly effective for hair loss treatment in Korea, with more side effects than finasteride.

The new 5% minoxidil foam is as effective and safe as Rogaine® for treating hair loss in Chinese men.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

5% minoxidil works better for hair growth than 1% minoxidil.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Low-dose oral minoxidil effectively promotes hair growth but has associated risks.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Oral minoxidil may have more cardiovascular risks than topical minoxidil.

Finasteride use may increase depression and suicide risk, especially at 1 mg, so monitoring is advised.

Topical minoxidil may cause more side effects than currently listed, needing updated safety information.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Finasteride use for hair loss is linked to an increased risk of suicidal thoughts and a higher risk of suicide.